Eugeni Domènech

Eugeni Domènech is an expert in Gastroenterology at Hospital Universitari Germans Trias i Pujol (Spain). As of October 2026, ScienceLeadR ranks Eugeni Domènech in the top 1% of experts worldwide for Colitis, Inflammatory Bowel Diseases and Gastroenteritis. Eugeni Domènech has authored 592 publications, the most recent in 2026, and is an investigator in 10 clinical trials, 2 of them ongoing. SLR score: 1,711 (community average: 125). How the SLR is computed.

Gastroenterology

Subspecialties: Hepatology - Pharmacy - Public Health

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on October 17, 2026

Expert Rankings

Top experts on the MeSH terms this expert works on

Top Colonic Diseases key opinion leaders

Organizations

Career arc: 1992 - 2026

Source: PubMed

Autonomous University of Barcelona

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 592

Citations

Citations: 8 396 1st author: 40 Last author: 167 Unique author: 2

Main journals

J Crohns Colitis 169

Gastroenterol Hepatol 83

Best Journals

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title	Journal	Year	Citations
Outcomes and Reclassification Patterns in Inflammatory Bowel Disease Unclassified: A Multicenter Study Matched With Ulcerative Colitis From Spanish ENEIDA Registry. PMID 42768837 — liver diseases, registries, colitis, gastroenterology, classification, inflammatory bowel diseases, therapeutics, biological therapy, colitis, ulcerative	J Gastroenterol Hepatol	2026	0
Systems biology integration of miR-mRNA profiles identifies steroid refractoriness mechanisms and biomarker candidates in ulcerative colitis. PMID 42597943 — glucocorticoids, colitis, adrenal cortex hormones, rna, messenger, systems biology, biomarkers, therapeutics, steroids, colitis, ulcerative	Biochem Biophys Rep	2026	0
Impact of Prior Biologic Mechanism of Action on Anti-TNF Effectiveness in Inflammatory Bowel Disease: An ENEIDA Registry Study. PMID 42581715 — registries, inflammatory bowel diseases, pharmacology, therapeutics, colitis, ulcerative	Aliment Pharmacol Ther	2026	2
Time trends in strategies for postoperative Crohn's disease management and long-term surgical recurrence: ENEIDA registry data. PMID 42456915 — registries, disease management, crohn disease, digestive system diseases	Clin Gastroenterol Hepatol	2026	0
Characterization of the stages of chronic liver disease based on plasma proteins involved in systemic inflammation. PMID 42439390 — liver diseases, procalcitonin, fibrosis, liver, biomarkers, infections, plasma	Rev Esp Enferm Dig	2026	0

Clinical Studies 10

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 1

By phase:

N/A 3

Phase 3 3

Phase 4 3

Phase 2/Phase 3 1

By status:

Completed 5

Recruiting 2

Terminated 2

Unknown 1

By type:

Interventional 8

Observational 2

By Monocentric/Multicentric:

monocentric 2

multicentric2to4 0

multicentric5to9 0

multicentricup10 8

Main Topics

Digestive System Diseases 7

Cohort/Consortium Investigators 7

Ongoing Clinical Trials

2 ongoing trials started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study	Phase	Status	Start
Immunological Characteristics of Preclinical IBD NCT05698745 — natural history, colitis, blood, serum, crohn disease, inflammatory bowel diseases, history, tissues, colitis, ulcerative, prospective studies, plasma	N/A	Recruiting	2024
Prospective Multicenter Randomized Comparative Study of the Treatment of de Novo Stenosis in Chron s Disease NCT04330846 — constriction, pathologic, crohn disease, treatment failure, therapeutics	N/A	Recruiting	2022

LeadR Networks

Main global connection map

Sources: PubMed, OpenAlex, ClinicalTrials, EU CTIS

Shopping Cart

System Maintenance Notice